Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 9 | 0 | 0 | 9 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 5 | 0 | 0 | 5 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 4 | 0 | 4 |
thioredoxin reductase | 14 | 0 | 0 | 14 |
GALC protein | 5 | 0 | 0 | 5 |
GLI family zinc finger 3 | 22 | 0 | 0 | 22 |
nuclear receptor subfamily 1, group I, member 3 | 15 | 0 | 0 | 15 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 14 | 0 | 0 | 14 |
glucocorticoid receptor [Homo sapiens] | 29 | 0 | 0 | 29 |
retinoic acid nuclear receptor alpha variant 1 | 20 | 0 | 0 | 20 |
retinoid X nuclear receptor alpha | 19 | 0 | 0 | 19 |
estrogen-related nuclear receptor alpha | 21 | 0 | 0 | 21 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
arylsulfatase A | 9 | 0 | 0 | 9 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 21 | 0 | 0 | 21 |
Bloom syndrome protein isoform 1 | 8 | 0 | 0 | 8 |
thyroid hormone receptor beta isoform a | 10 | 0 | 0 | 10 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 21 | 0 | 0 | 21 |
geminin | 21 | 0 | 0 | 21 |
peripheral myelin protein 22 | 8 | 0 | 0 | 8 |
survival motor neuron protein isoform d | 9 | 0 | 0 | 9 |
muscleblind-like protein 1 isoform 1 | 7 | 0 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit pi | 9 | 2 | 2 | 13 |
ATP-binding cassette sub-family C member 3 | 0 | 19 | 0 | 19 |
Multidrug resistance-associated protein 4 | 0 | 19 | 0 | 20 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 12 | 0 | 4 | 1 | 9 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
Bile salt export pump | 0 | 26 | 0 | 26 |
Glycogen phosphorylase, muscle form | 0 | 2 | 0 | 2 |
Renin | 0 | 3 | 0 | 3 |
Carbonic anhydrase 1 | 0 | 8 | 1 | 15 |
Carbonic anhydrase 2 | 0 | 9 | 1 | 16 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 3 | 0 | 4 | 1 | 8 |
Cathepsin B | 0 | 1 | 0 | 1 |
Cytochrome P450 3A4 | 0 | 6 | 1 | 8 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 8 | 0 | 8 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 15 | 0 | 15 |
5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
Androgen receptor | 0 | 7 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit beta-1 | 9 | 2 | 2 | 13 |
Translocator protein | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 9 | 2 | 2 | 13 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 9 | 2 | 2 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 9 | 2 | 2 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 9 | 2 | 2 | 13 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 8 | 1 | 12 |
Carbonic anhydrase 6 | 0 | 4 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 9 | 2 | 2 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 9 | 2 | 2 | 13 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 3 | 0 | 4 |
Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
Dipeptidyl peptidase 4 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 9 | 2 | 2 | 13 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 9 | 2 | 2 | 13 |
Endochitinase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 9 | 2 | 2 | 13 |
Adenosine receptor A2a | 0 | 4 | 0 | 5 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 3 | 0 | 3 |
Delta-type opioid receptor | 0 | 4 | 1 | 6 |
Cytochrome P450 2C19 | 0 | 5 | 0 | 5 |
Delta-type opioid receptor | 0 | 4 | 2 | 6 |
Mu-type opioid receptor | 0 | 6 | 2 | 8 |
Carbonic anhydrase 5A, mitochondrial | 0 | 6 | 1 | 11 |
Carbonic anhydrase | 0 | 5 | 0 | 6 |
Kappa-type opioid receptor | 0 | 3 | 1 | 4 |
Carbonic anhydrase 7 | 0 | 4 | 1 | 8 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 3 | 1 | 4 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
D(2) dopamine receptor | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 9 | 2 | 2 | 13 |
Gamma-aminobutyric acid receptor subunit beta-3 | 9 | 2 | 2 | 13 |
Gamma-aminobutyric acid receptor subunit beta-2 | 9 | 2 | 2 | 13 |
Cholinesterase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 5 | 2 | 7 |
Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 2 |
Squalene synthase | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 5 | 1 | 10 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 4 |
Carbonic anhydrase | 0 | 1 | 0 | 4 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Delta carbonic anhydrase | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Endochitinase A1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 2 | 1 | 5 |
GABA theta subunit | 9 | 2 | 2 | 13 |
Canalicular multispecific organic anion transporter 1 | 0 | 18 | 0 | 18 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 15 | 0 | 3 | 0 | 5 |
Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 4 | 0 | 7 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 9 | 2 | 2 | 13 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Carbonic anhydrase 14 | 0 | 4 | 1 | 9 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5B, mitochondrial | 0 | 5 | 1 | 10 |
AR protein | 32 | 0 | 0 | 32 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 9 | 0 | 0 | 9 |
Sex hormone-binding globulin | 0 | 0 | 5 | 5 |
Corticosteroid-binding globulin | 0 | 5 | 0 | 5 |
Mineralocorticoid receptor | 0 | 3 | 3 | 7 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 2 | 0 | 4 |
Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 13 | 0 | 0 | 13 |
Chain U, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 9 | 0 | 0 | 9 |
Chain B, HADH2 protein | 9 | 0 | 0 | 9 |
Chain A, 2-oxoglutarate Oxygenase | 5 | 0 | 0 | 5 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
acetylcholinesterase | 6 | 0 | 0 | 6 |
TDP1 protein | 21 | 0 | 0 | 21 |
aldehyde dehydrogenase 1 family, member A1 | 10 | 0 | 0 | 10 |
thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
regulator of G-protein signaling 4 | 6 | 0 | 0 | 6 |
estrogen nuclear receptor alpha | 31 | 0 | 0 | 31 |
glucocerebrosidase | 3 | 0 | 0 | 3 |
alpha-galactosidase | 3 | 0 | 0 | 3 |
cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform 2 | 17 | 0 | 0 | 17 |
huntingtin isoform 2 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 19 | 0 | 0 | 19 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 5 | 0 | 7 |
Prothrombin | 0 | 2 | 0 | 2 |
Coagulation factor X | 0 | 1 | 0 | 1 |
Plasminogen | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 2 | 0 | 2 |
Tissue-type plasminogen activator | 0 | 2 | 0 | 2 |
Cationic trypsin | 0 | 1 | 0 | 1 |
Coagulation factor XI | 0 | 1 | 0 | 1 |
Plasma kallikrein | 0 | 1 | 0 | 2 |
Vitamin K-dependent protein C | 0 | 1 | 0 | 1 |
Cellular tumor antigen p53 | 15 | 0 | 0 | 15 |
Urokinase-type plasminogen activator | 0 | 2 | 0 | 2 |
Trypsin-1 | 0 | 1 | 0 | 1 |
Trypsin-2 | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger 1 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger 1 | 0 | 2 | 0 | 2 |
Sodium/hydrogen exchanger 3 | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 3 | 1 | 4 |
Trypsin-3 | 0 | 1 | 0 | 1 |
Amiloride-sensitive sodium channel subunit alpha | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
Sodium/hydrogen exchanger 2 | 0 | 2 | 0 | 2 |
Acid-sensing ion channel 1 | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 4 | 0 | 4 |
Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
Sodium/hydrogen exchanger 5 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 4 | 0 | 5 |
Solute carrier family 22 member 2 | 0 | 5 | 0 | 6 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger | 0 | 1 | 0 | 1 |
Chain A, Cruzipain | 4 | 0 | 0 | 4 |
interleukin 8 | 3 | 0 | 0 | 3 |
phosphopantetheinyl transferase | 7 | 0 | 0 | 7 |
GLS protein | 7 | 0 | 0 | 7 |
farnesoid X nuclear receptor | 16 | 0 | 0 | 16 |
peroxisome proliferator-activated receptor delta | 15 | 0 | 0 | 15 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 18 | 0 | 0 | 18 |
tumor necrosis factor | 3 | 0 | 0 | 3 |
vitamin D3 receptor isoform VDRA | 6 | 0 | 0 | 6 |
Nuclear receptor ROR-gamma | 6 | 0 | 0 | 6 |
Aurora kinase B | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 4 | 0 | 4 |
DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
histone acetyltransferase KAT2A isoform 1 | 4 | 0 | 0 | 4 |
Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
Type-1A angiotensin II receptor | 0 | 3 | 1 | 4 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Type-1B angiotensin II receptor | 0 | 4 | 0 | 4 |
Type-1 angiotensin II receptor | 0 | 3 | 3 | 6 |
Type-2 angiotensin II receptor | 0 | 5 | 0 | 5 |
Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
ATAD5 protein, partial | 6 | 0 | 0 | 6 |
Microtubule-associated protein tau | 7 | 0 | 0 | 7 |
D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
NFKB1 protein, partial | 6 | 0 | 0 | 6 |
chromobox protein homolog 1 | 14 | 0 | 0 | 14 |
flap endonuclease 1 | 3 | 0 | 0 | 3 |
DNA polymerase iota isoform a (long) | 10 | 0 | 0 | 10 |
muscarinic acetylcholine receptor M1 | 7 | 0 | 0 | 7 |
lethal factor (plasmid) | 5 | 0 | 0 | 5 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 7 | 0 | 0 | 7 |
Beta-1 adrenergic receptor | 0 | 1 | 2 | 4 |
Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
Urease | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 4 | 2 | 6 |
Beta-1 adrenergic receptor | 0 | 4 | 2 | 6 |
Beta-3 adrenergic receptor | 0 | 2 | 2 | 4 |
5-hydroxytryptamine receptor 1A | 0 | 4 | 2 | 7 |
Alpha-1D adrenergic receptor | 0 | 1 | 1 | 3 |
Alpha-1A adrenergic receptor | 0 | 2 | 2 | 5 |
Alpha-1B adrenergic receptor | 0 | 1 | 1 | 3 |
TAR DNA-binding protein 43 | 7 | 0 | 0 | 7 |
Beta-2 adrenergic receptor | 0 | 2 | 2 | 6 |
Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 18 | 0 | 0 | 18 |
SMAD family member 2 | 9 | 0 | 0 | 9 |
Fumarate hydratase | 5 | 0 | 0 | 5 |
SMAD family member 3 | 9 | 0 | 0 | 9 |
thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
EWS/FLI fusion protein | 5 | 0 | 0 | 5 |
pregnane X nuclear receptor | 17 | 0 | 0 | 17 |
G | 8 | 0 | 0 | 8 |
polyprotein | 5 | 0 | 0 | 5 |
P53 | 1 | 0 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 12 | 0 | 0 | 12 |
IDH1 | 9 | 0 | 0 | 9 |
aryl hydrocarbon receptor | 10 | 0 | 0 | 10 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 14 | 0 | 0 | 14 |
thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
activating transcription factor 6 | 5 | 0 | 0 | 5 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 11 | 0 | 0 | 11 |
Histone H2A.x | 8 | 0 | 0 | 8 |
peripheral myelin protein 22 isoform 1 | 7 | 0 | 0 | 7 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
heat shock protein beta-1 | 8 | 0 | 0 | 8 |
cytochrome P450 3A4 isoform 1 | 9 | 0 | 0 | 9 |
M-phase phosphoprotein 8 | 5 | 0 | 0 | 5 |
Bile salt export pump | 0 | 5 | 0 | 5 |
Voltage-dependent calcium channel gamma-2 subunit | 10 | 0 | 0 | 10 |
Interferon beta | 12 | 0 | 0 | 12 |
HLA class I histocompatibility antigen, B alpha chain | 8 | 0 | 0 | 8 |
Glutamate receptor 2 | 10 | 0 | 0 | 10 |
Inositol hexakisphosphate kinase 1 | 8 | 0 | 0 | 8 |
ATPase family AAA domain-containing protein 5 | 6 | 0 | 0 | 6 |
Ataxin-2 | 7 | 0 | 0 | 7 |
Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 8 | 0 | 0 | 8 |
pregnane X receptor | 7 | 0 | 0 | 7 |
progesterone receptor | 17 | 0 | 0 | 17 |
nuclear receptor subfamily 1, group I, member 2 | 6 | 0 | 0 | 6 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 14 | 2 | 16 |
Glycine receptor subunit alpha-1 | 0 | 14 | 0 | 14 |
Glycine receptor subunit beta | 0 | 14 | 0 | 14 |
Glycine receptor subunit alpha-2 | 0 | 14 | 0 | 14 |
Glycine receptor subunit alpha-3 | 0 | 14 | 0 | 14 |
ORF73 | 0 | 0 | 1 | 1 |
Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
Thrombopoietin | 3 | 0 | 0 | 3 |
Metallo-beta-lactamase type 2 | 0 | 1 | 1 | 2 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Leukotriene A-4 hydrolase | 0 | 2 | 1 | 3 |
EEF1AKMT4-ECE2 readthrough transcript protein | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 6 | 1 | 7 |
Angiotensin-converting enzyme | 0 | 6 | 0 | 7 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 4 |
Endothelin-converting enzyme 1 | 0 | 1 | 0 | 1 |
Succinyl-diaminopimelate desuccinylase | 0 | 3 | 0 | 3 |
Angiotensin-converting enzyme | 0 | 4 | 0 | 4 |
Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
Beta-lactamase TEM | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 2 | 0 | 3 |
Beta-lactamase | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme 2 | 0 | 2 | 0 | 2 |
Beta-lactamase class B VIM-2 | 0 | 1 | 1 | 2 |
Protease | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 8 | 0 | 0 | 8 |
nonstructural protein 1 | 5 | 0 | 0 | 5 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 10 | 0 | 0 | 10 |
mitogen-activated protein kinase 1 | 6 | 0 | 0 | 6 |
serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 3 |
Solute carrier family 22 member 3 | 0 | 2 | 0 | 3 |
Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
C-8 sterol isomerase | 0 | 1 | 0 | 1 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
endonuclease IV | 3 | 0 | 0 | 3 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 1 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
USP1 protein, partial | 5 | 0 | 0 | 5 |
urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
plasminogen precursor | 4 | 0 | 0 | 4 |
urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 2 | 4 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP3 subtype | 0 | 3 | 1 | 4 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 2 | 4 |
Prostacyclin receptor | 0 | 4 | 2 | 6 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 3 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 3 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B2 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 7 | 0 | 0 | 7 |
Spike glycoprotein | 9 | 0 | 0 | 9 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
Smad3 | 7 | 0 | 0 | 7 |
67.9K protein | 7 | 0 | 0 | 7 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 | 6 | 0 | 0 | 6 |
unnamed protein product | 0 | 1 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
Histone deacetylase 3 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 2 | 0 | 0 | 2 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 2 | 0 | 2 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Heme oxygenase 1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 5 | 0 | 5 |
Lanosterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
Aromatase | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Heme oxygenase 2 | 0 | 1 | 0 | 1 |
Malate dehydrogenase, cytoplasmic | 0 | 2 | 0 | 2 |
Histone deacetylase 4 | 0 | 1 | 0 | 1 |
Cytochrome P450 144 | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Mycocyclosin synthase | 0 | 0 | 1 | 1 |
Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Histone deacetylase 1 | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 2 | 1 | 3 |
Sterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Sterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
Histone deacetylase 7 | 0 | 1 | 0 | 1 |
Histone deacetylase 2 | 0 | 1 | 0 | 1 |
Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
Histone deacetylase 11 | 0 | 1 | 0 | 1 |
14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
Histone deacetylase 8 | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
Histone deacetylase 9 | 0 | 1 | 0 | 1 |
Histone deacetylase 5 | 0 | 1 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
likely tRNA 2'-phosphotransferase | 0 | 1 | 0 | 1 |
estrogen receptor 2 (ER beta) | 8 | 0 | 0 | 8 |
thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
Albumin | 0 | 3 | 3 | 6 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 2 | 0 | 2 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 2 | 1 | 3 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 9 | 0 | 9 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 2 | 0 | 2 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Pancreatic alpha-amylase | 0 | 1 | 0 | 1 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 2 | 0 | 1 | 1 | 2 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 0 | 1 | 2 | 3 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Histamine H1 receptor | 0 | 1 | 2 | 3 |
Histamine H1 receptor | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Histamine H1 receptor | 0 | 2 | 2 | 4 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
Histamine H2 receptor | 4 | 0 | 1 | 5 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 2 | 3 |
Hsf1 protein | 0 | 0 | 2 | 2 |
cytochrome P450 2C9 precursor | 4 | 0 | 0 | 4 |
Luciferase | 4 | 0 | 0 | 4 |
importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
snurportin-1 | 2 | 0 | 0 | 2 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 3 | 0 | 3 |
Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
Albumin | 0 | 1 | 0 | 1 |
Albumin | 0 | 0 | 2 | 2 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Cholinesterase | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, intestinal | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 5 |
UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 3 | 0 | 3 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 4 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 4 | 0 | 4 |
Caspase-3 | 0 | 2 | 0 | 2 |
Caspase-4 | 0 | 2 | 0 | 2 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Caspase-5 | 0 | 2 | 0 | 2 |
Caspase-9 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 4 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Prostacyclin receptor | 0 | 1 | 1 | 2 |
Prostaglandin D2 receptor | 0 | 0 | 1 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 1 | 0 | 1 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily M member 2 | 0 | 1 | 0 | 1 |
Myc proto-oncogene protein | 0 | 1 | 0 | 1 |
Myeloperoxidase | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C4 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member C2 | 0 | 3 | 0 | 3 |
Aldo-keto reductase family 1 member C1 | 0 | 3 | 0 | 3 |
Peroxisome proliferator-activated receptor alpha | 2 | 0 | 0 | 2 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
bioA | 0 | 0 | 0 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 3E | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
Alpha-2A adrenergic receptor | 0 | 6 | 2 | 9 |
D(2) dopamine receptor | 0 | 3 | 1 | 4 |
Alpha-1B adrenergic receptor | 0 | 7 | 1 | 8 |
D | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 3 | 0 | 3 |
Alpha-2B adrenergic receptor | 0 | 2 | 1 | 3 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-2A adrenergic receptor | 0 | 2 | 1 | 3 |
Alpha-1D adrenergic receptor | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 4 | 1 | 5 |
5-hydroxytryptamine receptor 2C | 0 | 6 | 1 | 7 |
5-hydroxytryptamine receptor 1B | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 6 | 1 | 7 |
Alpha-1A adrenergic receptor | 0 | 7 | 1 | 8 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 3D | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 2 | 0 | 2 |
caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
caspase-3 | 3 | 0 | 0 | 3 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 2 | 0 | 0 | 2 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
PPM1D protein | 1 | 0 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 2 | 0 | 0 | 2 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Adenosine receptor A3 | 0 | 5 | 1 | 6 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 6 | 0 | 4 | 1 | 5 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
Adenosine receptor A1 | 0 | 3 | 0 | 3 |
Kappa-type opioid receptor | 0 | 1 | 0 | 2 |
Kappa-type opioid receptor | 0 | 1 | 2 | 3 |
Mu-type opioid receptor | 0 | 3 | 2 | 6 |
Delta-type opioid receptor | 0 | 3 | 2 | 6 |
Kappa-type opioid receptor | 0 | 3 | 3 | 7 |
Mu-type opioid receptor | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Hormone-sensitive lipase | 0 | 1 | 0 | 1 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
Parkin | 1 | 0 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
perilipin-5 | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 2 | 0 | 0 | 1 | 1 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
Integrin beta-3 | 2 | 0 | 0 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 3 |
Muscarinic acetylcholine receptor M4 | 0 | 0 | 0 | 1 |
Integrin alpha-IIb | 2 | 0 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 3 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 1 | 1 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Platelet-activating factor receptor | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 4 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 1 | 0 | 0 | 0 | 1 |
Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 2 | 0 | 0 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 3 |
Alpha-2B adrenergic receptor | 0 | 0 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 4 |
Alpha-2C adrenergic receptor | 0 | 1 | 2 | 4 |
D(1A) dopamine receptor | 0 | 1 | 1 | 2 |
Endothelin-1 receptor | 0 | 1 | 1 | 2 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Vpr | 1 | 0 | 0 | 1 |
Estrogen receptor | 0 | 2 | 1 | 3 |
Progesterone receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 2 | 1 | 3 |
Estrogen receptor beta | 0 | 1 | 1 | 2 |
procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
Chain A, PAPAIN | 1 | 0 | 0 | 1 |
putative alpha-glucosidase | 1 | 0 | 0 | 1 |
pyruvate kinase | 1 | 0 | 0 | 1 |
Janus kinase 2 (a protein tyrosine kinase) | 0 | 1 | 0 | 1 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
Cathepsin G | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
Cyclin-dependent kinase 4 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
G1/S-specific cyclin-D1 | 0 | 1 | 0 | 1 |
Casein kinase I isoform alpha | 0 | 1 | 0 | 1 |
Casein kinase I isoform delta | 0 | 1 | 0 | 1 |
Casein kinase I isoform epsilon | 0 | 1 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
Pteridine reductase 1 | 0 | 1 | 0 | 1 |
Urease subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 1 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
Transporter | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |